共 37 条
[1]
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
[J].
BMJ-BRITISH MEDICAL JOURNAL,
1994, 308 (6921)
:81-100
[5]
CANNON CP, 1994, ACTA CARDIOL, V49, P1
[6]
A PILOT TRIAL OF RECOMBINANT DESULFATOHIRUDIN COMPARED WITH HEPARIN IN CONJUNCTION WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ASPIRIN FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI)-5 TRIAL
[J].
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,
1994, 23 (05)
:993-1003
[7]
COMPARISON OF FRONT-LOADED RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR, ANISTREPLASE AND COMBINATION THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) 4 TRIAL
[J].
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,
1994, 24 (07)
:1602-1610